Starling Oncology (STLN) Cash from Investing Activities Growth (3y) (2023 - 2026)
Powered by 
Analysis
Starling Oncology (STLN) Cash from Investing Activities Growth (3y) (2023 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 90.36 Bn | 89.35 Bn | 15.19 Bn | -7.40% |
| 2 | Tenet Healthcare | 22.02 Bn | 19.85 Bn | 4.45 Bn | -3.90% |
| 3 | Encompass Health | 12.13 Bn | 11.99 Bn | 1.34 Bn | -22.39% |
| 4 | Davita | 11.78 Bn | 11.09 Bn | 1.16 Bn | 17.59% |
| 5 | Universal Health Services | 10.09 Bn | 9.95 Bn | 3.29 Bn | -11.34% |
| 6 | Ensign | 9.97 Bn | 9.65 Bn | 306.24 Mn | -148.83% |
| 7 | Chemed | 6.93 Bn | 6.89 Bn | 221.47 Mn | -19.56% |
| 8 | Pacs | 6.81 Bn | 6.64 Bn | 338.46 Mn | -152.21% |
| 9 | Concentra Group Holdings Parent | 4.32 Bn | 4.16 Bn | 192.10 Mn | - |
| 10 | Starling Oncology | 609.95 Mn | 568.85 Mn | 27.17 Mn | -26.75% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -26.75% |
| Mar 31, 2026 | -27.17% |
| Dec 31, 2025 | 68.07% |
| Sep 30, 2025 | 80.98% |
| Jun 30, 2025 | 50.99% |
| Mar 31, 2025 | 41.36% |
| Dec 31, 2024 | 42.33% |
| Sep 30, 2024 | 134.83% |
| Jun 30, 2024 | 217.29% |
| Mar 31, 2024 | 148.84% |
| Dec 31, 2023 | -62.54% |